Girentuximab (Anti-CA9 / Carbonic anhydrase 9)

Ask supplier a question | View on supplier's website

Girentuximab (Anti-CA9 / Carbonic anhydrase 9) is a chimeric monoclonal antibody that targets and binds to carbonic anhydrase IX (CAIX), a cell surface glycoprotein ubiquitously expressed in clear cell renal cell carcinoma (ccRCC). MW:145.5 KD.

Supplier	Selleck Chemicals
Product #	A2578
Sku #	A2578-1mg*5
Pricing	1mg*5, $790.00

Feedback